Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Fund of hedge fund group Olympia hires Sergio Heuer

Tuesday, May 24, 2011
Olympia Group announces that it has appointed Mr. Sergio Heuer as President and Chief Executive Officer. Since 2010, Sergio Heuer has been a Partner at Graham Capital International in Europe and has been actively involved in the firm's European fundraising effort, resulting, among other things, in the successful launch of Graham's first UCITS fund. M. Heuer has in excess of 20 years of experience in private equity investments, mainly sponsored by the Tudor Investment Group, a leading global hedge fund. He ran companies in a variety of industries and geographies, managed teams across various performance centres and focused on clients on a global basis.

Pascal Maeter, Chairman of the Supervisory Board, commented: "We welcome the appointment of Sergio as President of Olympia Group. His operating background in a variety of industries, in addition to direct experience at some of the world's highest performing hedge funds, is a rare set of skills which we look forward to harnessing for all of Olympia's investors, clients, employees and stakeholders." Sergio Heuer commented: "I look forward to working with the existing senior management, Guido Bolliger (CIO), Arnaud Beyssen (CFO), Marc Beheray in charge of Life Insurance and Olivier Lazar in charge of Private Banking and leading Olympia over the next phase of its growth, focusing on providing market leading solutions to all of its clients across our offices in Paris, London, New York and Zurich. In addition, I believe that the strength of the Olympia team has been evident through its industry leading investment processes over the past 22 years and I look forward to expanding our product offering to meet the challenges experienced by our clients."


Press release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t